News

Olmesartan Blood Pressure Medicine Linked to Celiac Disease Type Villous Atrophy

Olmesartan Benicar Villous Atrophy Celiac DiseaseI just received an email from the Celiac Disease Research Center at Columbia University regarding a study showing a possible association between a blood pressure medication and villous atrophy. The blood pressure medication is called olmesartan and it is also known as Benicar, Benicar HCT, Azor, and Olmetec.

According to this article, the three-year study was conducted by the Mayo Clinic in Rochester, Minnesota and it included 22 patients who had symptoms of celiac disease, but antibody blood tests did not support that diagnosis. During this study patients improved with discontinuation of the drug, while a gluten-free diet had had no impact on their Read More »

Pennsylvania Resolution Aims to Increase Celiac Disease Awareness Statewide

PA Legislature proclaims April ‘Celiac Disease Awareness Month.’

Ambler, PA, April 03, 2009 –(PR.com)– Legislation passed by the Pennsylvania House of Representatives General Assembly recognizes April 2009 as the state’s official ‘Celiac Disease Awareness Month’. With the passing of House Resolution 153 (HR 153), Pennsylvania takes the lead in raising awareness for celiac disease as the most common and most undiagnosed autoimmune disorder in the United States.

HR 153 was ratified unanimously, 196-0, on March 31st, 2009 with the assistance of its prime sponsor, state representative Craig A. Dally (R).

Geoffrey M. Roche, advocacy chairman for the National Foundation for Celiac Awareness (NFCA) and resident of Bethlehem, PA, collaborated extensively with representative Dally on the creation and development of HR153, and lobbied for its passage in the State House of Representatives.

“I would like to thank my State Representative, Craig Dally, and the entire State House for recognizing the impact this disease has on many Pennsylvanians and for assisting the National Foundation for Celiac Awareness in creating awareness that will ensure individuals with celiac get diagnosed, and correctly manage the disease.” says Roche. “I understand first hand the impact this disease has on one’s life and the need for education and awareness across our entire nation.”

The entire resolution in its entirety can be read on the National Foundation for Celiac Awareness website, www.celiaccentral.org.

Roche’s role in the successful sanctioning of HR153 and his passionate efforts on behalf of NFCA, stem from his personal experience with celiac disease, having been diagnosed with the autoimmune disorder just 11 months ago.

NFCA founder and president Alice Bast describes HR153 as, “‘The first step in reforming the US health care system in relation to autoimmune diseases, preventive care and chronic disease management.”

NFCA and Roche aim to pass similar resolutions in every state nationwide, providing assistance and resources for citizens working on legislative efforts for the purpose of spreading awareness of celiac disease, a disease which current estimates suggest affect 1 in every 133 Americans. Only 120,000 of individuals with the autoimmune digestive disorder, roughly 1 in every 4700, have been diagnosed.

“Early assessment of celiac is crucial in preventing the onset of complications such as other autoimmune disorders, serious illnesses, and some cancers for individuals with this disease.” says Bast.

Those interested in enacting legislation in their states should contact the NFCA at info@celiaccentral.org, by phone (215) 325-1306 ext.101, or visit the ‘Get Involved’ section on the NFCA website, www.celiaccentral.org for information.

Celiac disease is an autoimmune digestive disease that damages the small intestine and interferes with absorption of nutrients from food. It is triggered by consumption of the protein called gluten, which is found in wheat, barley and rye. Left untreated, people with celiac disease can develop further complications such as other autoimmune diseases, osteoporosis, thyroid disease, and some cancers. An estimated three million Americans have celiac disease, but only about 1 in every 4700 with the disease receives an accurate diagnosis. Currently, the only treatment is a lifelong gluten-free diet.

###

NFCA is a 501(c)(3) non-profit organization dedicated to raising awareness and funding for celiac disease that will advance research, education and screening amongst medical professionals, children and adults. Visit www.celiaccentral.org or call 215-325-1306 for further information.

Contact Information
National Foundation for Celiac Awareness
Whitney Ehret
215-325-1306
whitney@celiaccentral.org
www.celiaccentral.org

Professional Football Kicker to Attempt Guiness Record & Support Celiac Disease

 

On Sunday, October 10th, 2010, arena football kicker, Craig Pinto, will be kicking field goals for 12 straight hours, from 7:30am-7:30pm, with two goals in mind. First, he will be attempting to set a world record for most field goals kicked within that time frame, by having to make 500 field goals, from 40 yards out, but Craig’s main focus is to raise money and awareness for Celiac Disease.

KICKING 4 CELIAC was born out of the desire to show children and adults alike, that living with Celiac Disease will not Read More »

Reality TV Shows are Including the Reality of Celiac Disease

trumppic

By Nancy Lapid, About.com Guide to Celiac Disease

Celiac disease has been a topic on not one but two TV shows in the past few days. I hardly watch television, so I’m fortunate to have learned about these episodes from a fellow blogger, the Gluten-Free Optimist.
First, the cable network BBC America’s reality show Last Restaurant Standing had an episode (#13) in which competing restauranteurs were required to come up with food for celiac guests (and other “tricky customers”) without advance warning. This episode will be replayed; the schedule is posted on the BBC America site. Read More »

Researchers Develop A Faster Way To Diagnose Celiac Disease

John Libonati Gluten Free Works

The following article was written by Erika Gebel and reprinted by permision from Chemical and Engineering News.

Celiac Disease Gluten Sensitivity Test

Celiac Disease and Gluten Sensitivity Often Go Undiagnosed

Judging by their symptoms, people with celiac disease could have food poisoning, depression, or iron deficiency. As a result, doctors often have trouble diagnosing the serious immune disorder. To develop a better test for the disease, researchers have made a device that can detect nanograms of gluten antibodies, the hallmarks of celiac disease, in human Read More »

Seventy Percent of Canadians Support No Exemptions to Proposed Food Labelling Regulations for Allergic and Celiac Consumers

OTTAWA, Feb. 2 /CNW/ – Prime Minister Stephen Harper is being asked to act on the concerns of millions of Canadians with food allergies and celiac disease and listen to the advice of prominent national medical, consumer and health organizations and pass proposed federal food labelling regulations now. The Prime Minister is also encouraged to heed the results of a new public opinion poll showing close to 70% of Canadians want regulations to affect all pre-packaged food and beverages and not grant a special exemption for the beer industry.

According to Angus Reid Public Opinion, 67% of Canadians approve of the proposed rules so they apply to all food and beverage companies, while only 21% believe the government should change the proposed rules to exempt the brewery industry from Read More »

Shared Genes in Type 1 Diabetes and Celiac Disease

A 2008 study provides more evidence that there is a link between celiac disease and gluten. This article in Scientific American reviews the study.

Diabetes and celiac disease: A Genetic Connection
Patients with type 1 diabetes have been known to be more prone to another autoimmune disorder, celiac disease, in which gluten in wheat, rye and barley triggers an immune response that damages the small intestine or gut. Now there’s evidence that the two diseases have a genetic link: they share at least seven chromosome regions.

The discovery, published in this week’s New England Journal of Medicine, indicates that both diseases may be triggered by similar genetic and environmental mechanisms, such as certain foods, that cause patients’ immune systems to become overactive and destroy healthy instead of infected tissue. Previous research has found that celiac disease is five to 10 times more common in people with type 1 diabetes than in the general population, an editorial accompanying the study notes.

“These findings suggest common mechanisms causing both celiac and type 1 diabetes – we did not expect to see this very high degree of shared genetic risk factors,” said study co-author David van Heel, a gastrointestinal geneticist at Barts and the London School of Medicine and Dentistry.

Van Heel and his colleagues studied genetic material or DNA from about 20,000 people, half of them healthy, nearly half with type 1 diabetes, and 2,000 with celiac disease. The overlapping genetic variants occurred on regions of chromosomes (parts of cells that carry genetic code) that are believed to regulate the gut’s immune system, the BBC notes.

Type 1 diabetes occurs when a person’s immune system mistakenly attacks healthy beta cells in the pancreas that produce the hormone insulin, which is needed to convert glucose into energy. In celiac disease, a similar attack occurs on the small intestine when sufferers eat gluten-rich grains, causing inflammation in the gut that can lead to bloating, abdominal pain, nausea, constipation, diarrhea, fatigue, anemia, headaches, weight loss and failure to thrive in children. Whereas diabetes 1 patients must inject insulin daily to make up for their deficiency, people with celiac disease can avoid damage and symptoms by sticking to a gluten-free diet.

“The finding raises the question of whether eating cereal and other gluten products might trigger type 1 diabetes by altering the function of the gut and its interaction with the pancreas, the authors write. But Robert Goldstein, chief scientific officer of the Juvenile Diabetes Research Foundation, which helped fund the study, says it would be premature to assume from this study that gluten is also a diabetes trigger.

“I fear the newspaper headlines in the popular press will read like, ‘Eating wheat will cause type 1 diabetes,’” Goldstein tells us. “The presence or absence of these associations has to be linked to some biological consequence” for a person’s health.

Article Source: http://www.sciam.com/blog/60-second-science/post.cfm?id=diabetes-and-celiac-disease-a-genet-2008-12-11

*UK Study Source: Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease, New England Journal of Medicine. http://content.nejm.org/cgi/content/full/NEJMoa0807917

Smart Balance Acquires Glutino Food Group for $66.3 Million

John Libonati Gluten Free Works

On August 3, Smart Balance, Inc. announced it purchased Glutino Food Group for $66.3 million cash.  With this purchase, Smart Balance picks up arguably the #1 most recognized gluten-free brand in the United States.

Smart Balance Gluten FreePARAMUS, N.J., Aug. 3, 2011 /PRNewswire/ — Smart Balance, Inc. (NasdaqGM: SMBL) announced it acquired 100% of the equity interest of Importations DE-RO-MA, which owns Glutino Food Group (“Glutino”), for $66.3 million, from Claridge, aMontreal-based investment firm.  Based in Laval, Quebec, Glutino is a leading manufacturer and marketer of innovative, premium-priced, gluten-free foods sold under the Glutino and Gluten Free Pantry brands.  Glutino offers a wide range of shelf-stable and frozen gluten-free products, including snack foods, frozen baked goods, frozen entrees and baking mixes throughout North America and on its website www.glutenfree.com.  Glutino had annual sales of $53.9 million during its fiscal year ended March 31, 2011.

Commenting on the announcement, Chairman and Chief Executive Officer Stephen Hughes stated,

Read More »

Study reports those diagnosed with celiac disease have reduced subsequent healthcare costs

According to the National Digestive Diseases Information Clearing House, a study published in the December 2008 issue of the Journal of Insurance Medicine reports that researchers from Columbia University and CIGNA HealthCare found that diagnosis of celiac disease substantially reduces subsequent health care costs. 

The research group, led by Peter Green, M.D., a renowned authority in celiac disease from Columbia University,  looked at medical records for 10.2 million CIGNA managed care members.   Read More »

>